Clinical Trial of New Targeted Agent a Boon for Patient With AML | Dana-Farber Cancer Institute
Published: February 13, 2024Written by: Rob LevyWhen Youling Sun was diagnosed in Shanghai, China, with acute myeloid leukemia (AML) in 2018, he called his son, Conghao, in Boston, for advice. His son’s message was unequivocal: Come to Boston for your treatment. Today, Sun, a retired office worker from Shanghai, has multiple reasons to be thankful … Read more